Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Todt

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy functionToni Luise Meister, Yannick Brüggemann, Maximilian K Nocke, et al.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Journal of Hepatology|January 27, 2022
Hepatitis E virus is highly resistant to alcohol-based disinfectantsPatrick Behrendt, Martina Friesland, Jan-Erik Wißmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2024
MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2Rajendra Khanal, Natalie Heinen, Alexandra Bogomolova, et al.
Journal of Virology|March 4, 2021
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elementsBirthe Tegtmeyer, Gabrielle Vieyres, Daniel Todt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2020
Robust hepatitis E virus infection and transcriptional response in human hepatocytesDaniel Todt, Martina Friesland, Nora Moeller, et al.
Viruses|July 27, 2022
An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus InoculationMarcha Badenhorst, Armin Saalmüller, Janet M Daly, et al.
Journal of Hepatology|January 23, 2021
Hepatitis E virus persists in the ejaculate of chronically infected menThomas Horvatits, Jan-Erik Wißmann, Reimar Johne, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy functionToni Luise Meister, Yannick Brüggemann, Maximilian K Nocke, et al.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Journal of Hepatology|January 27, 2022
Hepatitis E virus is highly resistant to alcohol-based disinfectantsPatrick Behrendt, Martina Friesland, Jan-Erik Wißmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 23, 2024
MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2Rajendra Khanal, Natalie Heinen, Alexandra Bogomolova, et al.
Journal of Virology|March 4, 2021
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elementsBirthe Tegtmeyer, Gabrielle Vieyres, Daniel Todt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2020
Robust hepatitis E virus infection and transcriptional response in human hepatocytesDaniel Todt, Martina Friesland, Nora Moeller, et al.
Viruses|July 27, 2022
An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus InoculationMarcha Badenhorst, Armin Saalmüller, Janet M Daly, et al.
Journal of Hepatology|January 23, 2021
Hepatitis E virus persists in the ejaculate of chronically infected menThomas Horvatits, Jan-Erik Wißmann, Reimar Johne, et al.
Pageof 16